openPR Logo
Press release

Investigation announced for Investors in Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing

06-07-2023 08:20 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Zynex, Inc. (NASDAQ: ZYXI) shares over potential wrongdoing at Zynex, Inc.

An investigation on behalf of investors in Zynex, Inc. (NASDAQ: ZYXI) shares over potential wrongdoing at Zynex, Inc.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Zynex, Inc.

Investors who purchased shares of Zynex, Inc. (NASDAQ: ZYXI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Zynex, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Englewood, CO based Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. reported that its annual Total Revenue rose from $80.12 million in 2020 to $130.3 million in 2021, and that its Net Income increased from $9.07 million in 2020 to $17.1 million in 2021.

On March 6, 2023, Zynex postponed the release of its fourth quarter and full year financial results.
Shares of Zynex, Inc. (NASDAQ: ZYXI) declined from over $17 per share in January 2023 to $9.34 per share on March 07, 2023.

Those who purchased shares of Zynex, Inc. (NASDAQ: ZYXI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing here

News-ID: 3079979 • Views:

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, Inc. (NYSE: DV)
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, …
An investor, who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV), filed a lawsuit over alleged violations of Federal Securities Laws by DoubleVerify Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2025. NYSE: DV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Zynex

Electric Stimulation Devices Market Size, Competitive Outlook Medtronic, Zynex, …
Electric stimulation devices (ESDs) use electrical impulses to stimulate nerves and muscles for therapeutic purposes. These devices are widely used in pain management, rehabilitation, and muscle conditioning. They function by emitting controlled electrical currents through electrodes placed on the skin, which can help reduce muscle spasms, improve blood circulation, and promote tissue healing. Some devices, like Transcutaneous Electrical Nerve Stimulation (TENS) units, are designed to block pain signals to the
Muscle Stimulator Market Next Big Thing | Major Giants- Axiobionics, Zynex, Neur …
Pro Market Reports published a new research publication on "Muscle Stimulator Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Muscle Stimulator market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Pain Management Device Market May See Big Move: Medtronic, Cyberonics, Zynex
The latest study released on the Global Pain Management Device Market by HTF MI evaluates market size, trend, and forecast to 2030. The Pain Management Device market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key
Investigation announced for Investors in shares of Zynex, Inc. (NASDAQ: ZYXI)
An investigation was announced on behalf of investors of Zynex, Inc. (NASDAQ: ZYXI) shares over potential securities laws violations by Zynex, Inc. Investors who purchased shares of Zynex, Inc. (NASDAQ: ZYXI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Zynex, Inc. (NASDAQ: ZYXI) concerning whether
Neuro-Stimulators Market Analysis, Research Study With NeuroMetrix, Zynex, Nevro
Neuro-stimulators are a new way of controlling devices through the mind. Neuro-stimulators have a lot of different uses and they can be used to control (or set) everything from your TV remote, to steering wheel in your car, or even building elevators. The latest Neuro-Stimulators market research report is now available for you to review by A2Z Market Research. The report begins with an introduction to the Neuro-Stimulators market, including its
Electrotherapy Device Market New Study Offers Insights for 2028 | NeuroMetrix, Z …
Making investment in the products or services is done in an effective way to gain huge gains through this Electrotherapy Device market survey report. It highlights on competition level in the global market for the forecast period 2022-2028. It allows retail investors in tracking the marketing strategies for the purpose of getting right investment opportunities. This market research also assesses the status of the firm. It signifies the current condition